Researcher.Life Logo

Journal of Liver Cancer : Impact Factor & More

eISSN: 2383-5001pISSN: 2288-8128
JournalOpen Access
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Journal of Liver Cancer

Journal of Liver Cancer Journal Specifications

Overview
Publisher Korean Liver Cancer Association
Language English
Publication Time12
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
Society/Institute/SponsorKorean Liver Cancer Association
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 12
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicyJournal of Liver Cancer website > best practices > deposit policy
License typeCC BY-NC
OA statementVisit website
View less

Planning to publish in Journal of Liver Cancer ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Journal of Liver Cancer

Outcomes of Early-Stage HCC patients treated by resection or ablation: real-life data from the French administrative health care database (SNDS).
  • 14 May 2026
  • Journal of liver cancer
Combined hepatocellular-cholangiocarcinoma: a contemporary pathologic and molecular perspective.
  • 9 Mar 2026
  • Journal of liver cancer
Systemic treatment strategies for combined hepatocellular-cholangiocarcinoma: current evidence and future direction.
  • 1 Mar 2026
  • Journal of liver cancer
Alcohol-related hepatocellular carcinoma: surveillance and primary prevention.
  • 1 Mar 2026
  • Journal of liver cancer
The role of radiotherapy in the management of combined hepatocellular-cholangiocarcinoma: current evidence and future perspectives.
  • 1 Mar 2026
  • Journal of liver cancer
Systemic therapy for combined hepatocellular-cholangiocarcinoma: a comprehensive review of chemotherapy, immunotherapy, and targeted therapy.
  • 1 Mar 2026
  • Journal of liver cancer
Outcomes of Early-Stage HCC patients treated by resection or ablation: real-life data from the French administrative health care database (SNDS).
  • 14 May 2026
  • Journal of liver cancer
Combined hepatocellular-cholangiocarcinoma: a contemporary pathologic and molecular perspective.
  • 9 Mar 2026
  • Journal of liver cancer
Systemic treatment strategies for combined hepatocellular-cholangiocarcinoma: current evidence and future direction.
  • 1 Mar 2026
  • Journal of liver cancer
Alcohol-related hepatocellular carcinoma: surveillance and primary prevention.
  • 1 Mar 2026
  • Journal of liver cancer
The role of radiotherapy in the management of combined hepatocellular-cholangiocarcinoma: current evidence and future perspectives.
  • 1 Mar 2026
  • Journal of liver cancer
Systemic therapy for combined hepatocellular-cholangiocarcinoma: a comprehensive review of chemotherapy, immunotherapy, and targeted therapy.
  • 1 Mar 2026
  • Journal of liver cancer

FAQs on Journal of Liver Cancer